FLUAD
- Product NDC
- 70461-019
- 11-digit product format
- 704610019
- Labeler code
- 70461
- Product ID
- 70461-019_97c3669d-ac04-4c97-b2ab-2ce4d0bf6e12
- Type
- VACCINE
- Nonproprietary name
- Influenza Vaccine, Adjuvanted
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Labeler
- Seqirus, Inc.
- Application
- BLA125510
- Marketing category
- BLA
- Marketing start
- 2015-11-24
- Marketing end
- 2020-07-31
- Substance
- INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED)
- Active strength
- 15 ug/.5mL; ug/.5mL; ug/.5mL
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 125510 | Fluad | Influenza Vaccine, Adjuvanted | 351(a) | Disc | 2026-06-01 |